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Background: Postherpetic neuralgia is spontaneous pain and allodynia that persist long after the disappearance
of the cutaneous lesions caused by herpes zoster. Inoculation of mice with herpes simplex virus-1 causes herpes
zoster-like skin lesions and herpetic and postherpetic pain. Although NMDA receptors have been suggested to
be involved in postherpetic pain as in other types of neuropathic pain, the neural mechanism remains unclear.
NMDA receptor NR2B subunit is the most tyrosine-phosphorylated protein in the brain, and Tyr1472 is the major
phosphorylation site of this subunit.
Results: To elucidate the role of Tyr1472 phosphorylation of the NR2B subunit in herpetic and postherpetic
allodynia, we inoculated herpes simplex virus-1 into the unilateral hind paw of knock-in mice with a mutation of
Tyr1472 of the NR2B subunit to Phe (Y1472F-KI). On day 7 post-inoculation, acute herpetic allodynia was observed
in more than 80% of the inoculated wild-type and Y1472F-KI mice. Y1472F-KI mice showed significantly reduced
intensity and incidence of postherpetic allodynia on days 45–50 post-inoculation as compared with wild-type
mice. The innervation in the skin at the postherpetic neuralgia phase was retained to a greater extent in the
Y1472F-KI mice. The level of activating transcription factor-3 mRNA, a marker of axonal damage, increased
much less in the dorsal root ganglia (DRGs) of Y1472F-KI mice than in those of wild-type mice; and the level
of nerve growth factor mRNA significantly increased in wild-type mice, but not at all in Y1472F-KI mice on day 7
post-inoculation. Production of nerve growth factor was at the basal level in the skin of both groups of mice on
day 50 post-inoculation. Nerve growth factor and glial cell-derived neurotrophic factor stimulated neurite
outgrowth of cultured DRG neurons from Y1472F-KI mice, similarly or less so as they did the outgrowth of
those from wild-type mice. Wild-type DRG neurons were more susceptible to glutamate neurotoxicity than
Y1472F-KI ones.
Conclusions: Taken together, the present data suggest that phosphorylation of the NR2B subunit at its Tyr1472 is
involved in the development of postherpetic allodynia due to nerve damage and that the nerve damage at the
acute herpetic phase is correlated with the incidence of postherpetic pain.* Correspondence: ito@takii.kmu.ac.jp
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Herpes zoster, which is characterized by clustered vesi-
cles in the skin and severe pain, is caused by the reacti-
vation of varicella zoster virus (VZV, human herpes
virus type-3), in the sensory ganglia of humans [1].
Patients with herpes zoster complain of severe spontan-
eous pain and allodynia, which is pain due to a non-
noxious stimulus. In some herpes zoster patients, pain
persists long after healing of the skin lesions, so-called
postherpetic neuralgia [1]. Once established, postherpe-
tic neuralgia is particularly difficult to treat and is often
resistant to conventional analgesics. The neural mechan-
isms of the induction and maintenance of postherpetic
neuralgia are still unclear.
Takasaki et al. [2,3] previously established a mouse
model of herpetic and postherpetic pain by using human
herpes virus 1 (herpes simplex virus type-1, HSV-1).
When mice were given a transdermal HSV-1 inoculation
into a hind paw, they showed herpes zoster-like skin
lesions throughout the inoculated dermatome and pain-
related behaviors [2]. Pain-related behaviors (herpetic
allodynia) and vesicles became apparent 5 days after the
inoculation, and the skin lesions healed 10 days later
[2,3]. In one-third of the mice, the pain-related behaviors
subsided by day 20 post inoculation; and in the rest of
the mice, such behaviors (postherpetic allodynia) lasted
long after the skin lesions had completely healed [3,4].
Based on data they had obtained by using this mouse
model, Sasaki et al. [4] recently suggested that herpetic
and postherpetic allodynia are mediated by nitric oxide
(NO) in the dorsal horn and that inducible nitric oxide
synthase (iNOS) and neuronal NOS (nNOS) are respon-
sible for herpetic and postherpetic allodynia, respect-
ively. Many studies including ours have demonstrated
that activation of the NMDA subtype of glutamate
receptors and subsequent NO production is a funda-
mental event in neurotransmission and synaptic plasti-
city in pain transmission in the spinal cord [5,6]. Garry
et al. [7] demonstrated that the VZV-induced pain state
is attenuated by intrathecal administration of an NMDA
receptor antagonist and that the profile of VZV
infection-induced phenotype changes in dorsal root gan-
glia (DRGs) are similar to those in other neuropathic
pain models. We showed earlier that an increase in
nNOS activity associated with Tyr1472 phosphorylation
of the NR2B subunit in the superficial dorsal horn of the
spinal cord reflects the neuropathic pain state even
1 week after nerve injury [8]. For elucidation of the role
of Tyr1472 phosphorylation of the NR2B subunit
in vivo, knock-in mice in which Tyr1472 of the NR2B
subunit is mutated to phenylalanine (Y1472F-KI) were
previously generated; and the results showed that
Tyr1472 phosphorylation is critical for neuropathic pain
and fear learning [9-11]. In the present study, we tookadvantage of this mouse model of herpetic and posther-
petic pain produced by HSV-1 inoculation, in which
alterations of levels of signaling molecules in the pain
transmission pathway can be followed over 7 weeks in
relation to pain-like behaviors in vivo. Applying this
model to Y1472F-KI mice, we examined the role of
NR2B phosphorylation in herpetic and postherpetic
allodynia.
Results
Involvement of NR2B phosphorylation in postherpetic
allodynia
HSV-1 was inoculated into the shin region of C57BL/6
(wild-type) and Y1472F-KI mice to generate a model
for herpetic and postherpetic allodynia. On day 7 post-
inoculation, shingles were observed along the lumbar
dermatome in both groups of mice (data not shown).
Mechanical allodynia of the hind paw was detected
in more than 80% of mice of either kind on day 7 post-
inoculation, and there was no difference in the pain-
related score between wild-type and Y1472F-KI mice
(0.75 ± 0.08, n= 19 and 0.85 ± 0.06, n= 17, respectively;
Figure 1A). Of 32 wild-type mice examined, 26 had allo-
dynia even 7 weeks after inoculation; and 10, strong allo-
dynia on days 45 to 50 (Figure 1B), indicating the
occurrence of postherpetic allodynia. As compared with
that for wild-type mice, the average pain-related score
for the Y1472F-KI mice gradually decreased and became
significantly lower than that for the wild-type mice by
day 35 and thereafter (Figure 1A). On days 45 to 50
post-inoculation, no Y1472-KI mouse exhibited strong
allodynia; and 12 of 29 Y1472-KI mice showed moderate
allodynia. These results suggest that the phosphorylation
of Tyr1472 in the NR2B subunit of NMDA receptors
affected the development of postherpetic allodynia, but
not that of acute herpetic allodynia.
Restoration of the structure and innervation of the skin
Sections of the hindlimb skin of both naive wild-type
and Y1472F-KI mice were examined by hematoxylin-
eosin staining. The epidermal layer was observed
(arrow), and hair follicles were seen in the dermal layer,
in both kinds of mice; and there was no apparent differ-
ence in the skin structure between the 2 groups. The
epidermal layer destroyed by shingles on day 7 post-
inoculation was restored, and the skin structure with
hair follicles was restored by day 50, in both wild-type
and Y1472F-KI mice (Figure 2).
Skin innervation was evaluated by immunostaining
for protein gene product 9.5 (PGP9.5), a pan-neuronal
marker. Nerve fibers were observed in both epidermis
and dermis, and there was no difference in PGP9.5
expression between naive wild-type and Y1472F-KI mice
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Figure 1 Reduction in postherpetic neuralgia in Y1472F-KI
mice. (A) Time-course analysis of mechanical allodynia after HSV-1
inoculation. Wild-type and Y1472F (YF) mice were inoculated with
HSV-1 on lacerated shin skin. At various times post inoculation, the
plantar was stimulated by use of a von Frey filament (1.6 mN), and
the response was assessed as pain-related score. Data are presented
as the mean± SEM (n= 19 and 17 in wild-type and Y1472F-KI mice,
respectively). *P< 0.05 vs. wild-type mice (Mann-Whitney's U-test).
(B) Comparison of the intensity of allodynia between wild-type and
Y1472F-KI mice. Mice were categorized into 3 groups according
to the pain-related score: low (< 0.5), moderate (0.5–0.9), and high
(≥ 1.0). Data are presented as percentage of total mice tested, and












Figure 2 Histological analysis of the skin of wild-type and
Y1472F-KI mice. The hindlimb skin in the lumbar dermatome was
harvested from wild-type and Y1472F-KI mice before and days 7
and 50 after HSV-1 inoculation. Cross sections were stained with
hematoxylin and eosin, and representative images are shown.
Arrows indicate the epidermis. Scale bars = 200 μm.
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wild-type mice, but their total length (0.39 ± 0.25 mm
per mm width of epidermis) in the affected skin was as
low as 22% of that (1.78 ± 0.18 mm) detected on thecontralateral side (Figure 3B). On the other hand, the
total length of nerve fibers (1.02 ± 0.55 mm) in the
epidermis of the affected skin in the Y1472F-KI mice
was 60% of that (1.70 ± 0.25 mm) detected on the
contralateral side. Thus, the total length of nerve fibers
in the affected epidermis was significantly greater in the
Y1472F-KI mice than in the wild-type ones. The sen-
sory nerve fibers in the epidermis were also examined
in terms of calcitonin gene-related peptide (CGRP)-
immunoreactivity. The number of CGRP-positive fibers
was 5.43 ± 2.92 and 6.79 ± 2.77 fibers/mm of epidermis
in wild-type and Y1472F-KI mice, respectively, being
36% and 60% of that of the contralateral side in the epi-
dermis (Figure 3C). These results show that the
innervation in the skin at the postherpetic neuralgia
phase was less damaged or more restored in the Y1472F-
















































































Figure 3 Cutaneous innervation of wild-type and Y1472F-KI mice at postherpetic neuralgia phase. (A) PGP9.5 immunostaining of
nerve fibers in the skin. Cross sections of the hindlimb skin from wild-type and Y1472F-KI mice before and days 7 and 50 after inoculation
were immunostained with anti-PGP9.5 antibody (red), and the nuclei were counterstained with DAPI (green). Arrows and arrowheads indicate
epidermis and nerve fibers, respectively. Scale bars = 50 μm. (B, C) Total length of PGP9.5-immunoreactive nerves (B) and the number of
CGRP-immunoreactive nerve fibers (C) in the epidermis. Intraepidermal nerve fibers immunoreactive for PGP9.5 and CGRP were measured in the
affected skin and contralateral skin from wild-type and Y1472F-KI mice on day 50 post-inoculation, as described in the Methods section.
Data are presented as the mean± SD (n= 6 and 8 for PGP9.5, and 5 and 6 for CGRP, in wild-type and Y1472F-KI mice, respectively). *P< 0.05
(Bonferroni t-test).
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NGF, a neurotrophic factor, is produced after skin
injury and stimulates nerve regeneration [12]. On day 50
post-inoculation, the NGF content in the affected skin
(0.60 ± 0.34 pg/mg) of wild-type mice was not different
from that in their contralateral skin (0.60 ± 0.17 pg/mg)
or in the affected skin of Y1472F-KI mice (0.62 ±
0.20 pg/mg; Figure 4A). NGF production was induced
after skin wounding (see Methods section for proced-
ure): NGF contents were increased approximately 5-fold
in the normal skin of wild-type and Y1472F-KI mice
(3.1 ± 0.77 and 2.2 ± 0.30 pg/mg of skin, respectively;
Figure 4B). Taken together, these results suggest that the
NGF production in the skin had subsided after healing
of shingles at the postherpetic neuralgia phase.Expression of neurotrophins in DRG
To further clarify the difference in the incidence of post-
herpetic allodynia and the innervation of the skin be-
tween wild-type and Y1472F-KI mice, we examined the
expression of activating transcription factor-3 (ATF3)
and neurotrophins in the DRG on days 7 and 50 post-
inoculation (Figure 5). It was earlier reported that ATF3
expression is induced in DRGs in response to nerve
injury but not to demyelination and that ATF3 should
thus be regarded as a neuronal marker of nerve injury
[13]. The expression of ATF3 was markedly increased in
the DRG on the inoculated side as compared with that
in the contralateral DRG on day 7 post-inoculation, and
the extent of increase was significantly lower in Y1472F-











































Figure 4 NGF contents in the skin. NGF contents in the skin of
the affected and contralateral hindlimbs of wild-type and Y1472F-KI
mice on day 50 post-inoculation (A) and in the back skin at 24 h
after wounding (B) were measured by ELISA. Data are presented as
the mean± SD (n= 3 for wild-type, and 5 (A) or 3 (B) for Y1472F-KI
mice. *P< 0.05 (Bonferroni t-test).
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ively). The increased ATF3 expression was reduced but
retained on day 50 in the DRG of both wild-type and
Y1472F-KI mice (3.0 ± 0.6 vs. 3.1 ± 2.4 fold). In contrast,
NGF expression was markedly increased 3.2 fold and 4.6
fold on days 7 and 50 post-inoculation, respectively, in
the wild-type DRGs, but not at all in the Y1472F-KI
ones. On the other hand, brain-derived neurotrophic
factor (BDNF) and glial cell-derived neurotrophic factor(GDNF) expressions were similarly increased in the
affected DRGs of both wild-type and Y1472F-KI mice
on day 7 post-inoculation (BDNF: 7.2 fold and 5.8 fold,
respectively; GDNF: 6.0 fold and 4.9 fold, respectively).
On day 50, although the increase in GDNF expression
was retained in the affected DRG of both wild-type and
Y1472F-KI mice (4.7 fold and 3.3 fold, respectively),
the expression of BDNF had returned to its basal level
by day 50. Neurotrophin 3 (NT3) expression was not
increased significantly in the affected DRG of either
wild-type or Y1472F-KI mice on days 7 and 50. In terms
of neurotrophin receptors, the expression levels of TrkA
for NGF; GFRα1, α2, and Ret for GDNF; and p75NTR
were not more than twice those of the contralateral side
on day 50 post-inoculation in either group of mice (data
not shown). These results demonstrate that the expres-
sion of AFT3, a neuronal marker of nerve injury, was
significantly low in the injured DRG of Y1472F-KI mice
as compared with that in the wild-type DRG on day 7
after HSV-1 inoculation and that the NGF expression
was not increased in the injured DRG of Y1472F-KI
mice, either on day 7 or on day 50 after inoculation.Decrease in intensity of NGF- and GDNF-sensitive fibers
in the dorsal horn of the spinal cord at postherpetic
neuralgia
To examine whether the difference in the expression of
NGF and GDNF in the injured DRG affected the central
terminals of primary afferent fibers, we detected NGF-
and GDNF-sensitive fibers by immunolabeling for CGRP
and substance P (SP) and by α-D-galactosyl-binding lec-
tin B4 (IB4), respectively, in the dorsal horn of the spinal
cord on day 50 post-inoculation (Figure 6). NGF-
sensitive fibers immunoreactive for CGRP and SP were
decreased to 40–50% of their fluorescence intensity on
the contralateral side in both wild-type and Y1472F-KI
mice. GDNF-sensitive fibers labeled with IB4 were also
decreased in intensity in both wild-type and Y1472F-KI
mice, but the extent of the decrease was lower in
Y1472F-KI mice (68%) than in the wild-type ones (82%).
To examine whether NMDA receptor channels were
regulated by NGF and GDNF, we measured the NMDA
(50 μM)-induced currents from substantia gelatinosa
(SG) neurons in the spinal dorsal horn serially in the
absence and presence of 0.1 μg/ml NGF. The NMDA-
induced currents were significantly increased by NGF in
Y1472F-KI mice (143.6% ± 9.6%, n= 4) but not in wild-
type mice (96.1% ± 3.6%, n= 5; Figure 7A). Conversely,
the NMDA-induced currents were significantly attenu-
ated by GDNF in Y1472F-KI mice (71.2%± 9.3%, n= 5),
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Figure 5 Alterations of gene expression of neurotrophins in the DRG after HSV-1 infection. Total RNAs were extracted from L4–L5 DRGs of
wild-type and Y1472F-KI mice on days 7 and 50 post-inoculation, and cDNAs were synthesized and amplified by quantitative real-time PCR with
the primers shown in the Methods section. Gene expression levels of ATF3 and neurotrophins (NGF, GDNF, BDNF, and NT3) were normalized to
the GAPDH level, and are presented as the fold change in the ratio of the affected side to the contralateral one. Data show the mean± SD
(n = 3–8). * P< 0.05 (Bonferroni t-test).
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To further clarify whether phosphorylation of Y1472 of
NR2B subunit was involved in regeneration of damaged
axons or neurotoxicity, we used a DRG culture system
in vitro to measure the neurite outgrowth and release of
lactate dehydrogenase (LDH). As shown in Figure 8A,
NGF at 10 ng/ml increased the neurite outgrowth of
DRG neurons prepared from wild-type and Y1472F-KI
mice to a similar extent (2.4- and 2.9-fold change rela-
tive to the control). On the other hand, GDNF (10 ng/ml)
increased the outgrowth of neurites from the wild-type
DRG (1.9 fold), but not that of those from the Y1472F-KI
DRG (1.3 fold). By increasing the concentration of GDNF
from 10 to 100 ng/ml, neurite outgrowth from Y1472F-KI
DRG reached the same level as in the wild-type one.
Axotomy of the sciatic nerve 7 days before preparation of
DRG cultures increased the neurite outgrowth in DRGs
from both wild-type and Y1472F-KI mice.
Finally we examined glutamate neurotoxicity toward
DRG neurons by measuring LDH release. When DRG
neurons were cultured with glutamate at 0.5 mM for
24 h, it did not cause the release of LDH from Y1472F-
KI DRG neurons; whereas it significantly increased the
release from the naive wild-type ones (Figure 8B).Discussion
Involvement of Tyr1472 phosphorylation of NR2B subunit
in postherpetic pain
By using wild-type and Y1472F-KI mice as nerve injury
models, we recently demonstrated that phosphorylation
of the NR2B subunit of the NMDA receptor is involved
in neuropathic pain [10,11]. Y1472F-KI mice are born in
the expected Mendelian ratios, appear healthy in terms
of general behaviors, and show normal gross cytoarchi-
tecture in their brain and spinal cord [9,10]. The expres-
sion level of NR2B and the basic properties of NMDA
receptors are absolutely normal in the amygdala [9] and
spinal cord [10] of Y1472F-KI mice. However, the Ca2+
response to glutamate is reduced after L5 spinal nerve
transection injury, and the impaired NMDA receptor-
mediated CaMKII signaling does not produce neuro-
pathic pain, in Y1472F-KI mice [10]. In this study, we
demonstrated by use of Y1472F-KI mice as an estab-
lished mouse model of postherpetic pain that phosphor-
ylation of the NR2B subunit affected in a positive
manner the incidence of postherpetic allodynia, but not
acute herpetic allodynia. In the wild-type mice inocu-
lated with HSV-1, all mice developed mechanical allody-
nia; and in 81% of them the pain was sustained even
CGRP















































Figure 6 Immunoreactivities of CGRP and SP, and IB4 labeling in the dorsal horn of spinal cord at postherpetic neuralgia phase. Cross
sections of the spinal cord of wild-type and Y1472F-KI mice at the postherpetic neuralgia phase (day 50) were immunostained with anti-CGRP
and anti-SP antibodies and labeled with IB4. A representative image of the dorsal horn region of each mouse is shown, and insets depict higher
magnification of the image delineated by the rectangles. The percentage of immunoreactive intensity in the dorsal horn (dotted line) was
determined, and the data are presented as the ratio of the affected side to the contralateral one (n= 5). *P< 0.05 (two-tailed Student's t-test).
Scale bars = 200 μm for low-power photos and 50 μm for high-power ones.
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tom of postherpetic neuralgia (Figure 1). The behavioral
results are consistent with previous studies with the
same animal model [3,4]. On the other hand, all
Y1472F-KI mice also developed allodynia on day 7 after
HSV-1 inoculation, but the pain-related score was sig-
nificantly decreased after day 35; and allodynia was
detected in only 41% of the mice on day 50 post-inocula-
tion. There was no Y1472F-KI mouse with strong pain.
The attenuation of postherpetic pain in Y1472F-KI mice
is consistent with the results of a previous study using
an NMDA receptor antagonist [7], which suggested that
the NMDA receptor signaling pathway is involved in the
development of postherpetic pain. Histochemical studies
on adult DRG show 2 broad classes of unmyelinated C
fibers: The population positive for CGRP/SP and TrkA,
the high-affinity receptor for NGF, represents roughly 40%
of DRG neurons in rodents; whereas the IB4-binding,
GDNF-sensitive population represents roughly 30% [14].
NMDA-induced currents in the spinal cord were signifi-
cantly attenuated by GDNF and enhanced by NGF in
Y1472F-KI mice, but not in wild-type mice (Figure 7A).
The decrease in GDNF-sensitive fibers labeled with IB4was 68% in Y1472F-KI mice, lower than that in wild-type
mice (82%), suggesting that GDNF might contribute to
the reduction of intensity of postherpetic pain. Interest-
ingly, the NGF mRNA level increased on days 7 and 50
post-inoculation only in the DRGs of wild-type mice, but
not in those of Y1472F-KI mice (Figure 5).
Although NGF/TrkA signals are reported to contribute
to the development and maintenance of neuropathic
pain [15,16], the role of NGF in the development of post-
herpetic pain remains unknown.
Higher density of nerve fibers in the skin associated with
reduction in postherpetic allodynia in Y1472F-KI mice
NMDA receptors located in the synaptic membranes of
the spinal cord play an important role in neuropathic
pain and postoperative pain due to neuronal plasticity
and central sensitization [17-19]. NMDA receptors are
also expressed in peripheral tissues and DRG neurons
[20-22], suggesting a potential role of NMDA receptors
in pain processing in the periphery [23,24]. On day 7 post-
inoculation, shingles were observed along the lumbar
dermatome, and the skin structure and cutaneous inner-





































































Figure 7 Effects of NGF and GDNF on NMDA-induced currents in spinal SG neurons. Representative traces of NMDA (50 μM)-induced
currents in the absence and presence of 0.1 μg/ml NGF (A) or GDNF (B) in wild-type (WT) and Y1472F-KI (YF)mice are shown. The holding
potentials were −40 mV. Data (mean± SEM, n= 4 or 5) are expressed as relative current amplitude induced by NMDA together with NGF or
GDNF to that by NMDA alone. *P< 0.05 vs. NMDA alone.
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cutaneous innervation was markedly reduced in the
wild-type mice even on day 50 (Figure 3). In Y1472F-KI
mice, the degree of cutaneous innervation on the injured
side also decreased, as compared with the contralateral
side; but the extent of decrease was less than that on
the injured side of the wild-type mice. Since cutaneous
innervation was markedly decreased in the injured side
of Thy1-YFP mice on day 7 after inoculation (Additional
File 1: Figure S1), the disappearance of PAG9.5 immu-
noreactivity in the skin on day 7 (Figure 3) was due to
the loss of nerve fibers rather than the alteration in
immunoreactivity. It has been reported that cutaneous
innervation is decreased in patients with postherpetic
neuralgia and that intraepidermal nerve fiber density is
negatively correlated with the severity of pain in patients
with herpes zoster [25-27] as well as in those with other
sensory neuropathies and in several animal models [28-30].
In fact, it was reported that excision of painful skin relieved
long-lasting postherpetic pain in a patient [31].Reduced damage to peripheral nerve results in reduced
postherpetic allodynia
DRG neurons contain NR1, NR2B, NR2C, and NR2D,
but not NR2A, subunits [20]. Furthermore, NR2B subu-
nits are predominantly expressed on small-diameter pri-
mary afferents [21]. There are 2 possibilities for higher
density of nerve fibers in the skin of Y1472F-KI mice
(Figure 3): reduced damage to nerve fibers and better
regeneration of lost nerve fibers in the skin. The findings
in the present study demonstrate that Tyr1472 phos-
phorylation of NR2B subunit was involved in the dam-
age to nerve fibers for the following reasons: (1) When
herpes virus (HSV-1 or VZV-infected cells) is inoculated
transdermally, the viral DNA and the gene products are
detected in the DRGs and alter the gene expression of
neuropeptides and ion channels in these ganglia [2,7].
ATF3 is highly induced in all injured DRG neurons after
peripheral nerve injury, and the increase in the number
of ATF3-positive DRG neurons is correlated positively





























































Figure 8 Neurite outgrowth and neurotoxicity of DRG neurons. (A) Neurite outgrowth of DRG neurons by NGF and GDNF. L4–L6 DRGs
were harvested from naive or axotomized (AX) wild-type and Y1472F-KI mice at 4–5 weeks of age. DRG neurons were grown in the presence
or absence of NGF (10 ng/ml) or GDNF (10, 50 or 100 ng/ml) for 22–26 h. Neurite outgrowth, shown in the photo, is presented as a percentage
of total DRG cells. Data are presented as the mean± SD (n= 3, 4, and 2 for NGF, GDNF, and axotomy, respectively). *P< 0.05 (two-tailed
Student's t-test). (B) Neurotoxicity of glutamate toward DRG neurons. DRG neurons prepared from naive wild-type and Y1472F-KI mice were
incubated without or with the indicated concentrations of glutamate for 24 h. The release of LDH was measured as described in the Methods
section. Experiments (n= 5–6 at each concentration) were carried out by using 3 independent preparations. Data are presented as the mean± SD
of 3 experiments. *P< 0.05 vs. Y1472F-KI mice (two-tailed Student's t-test).
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in Y1472F-KI mice, and the increased expression was
still retained on day 50 (Figure 5), indicating that axonal
damage was more severe in the skin of wild-type mice
than in that of Y1472F-KI mice. Similarly, GDNF-
sensitive neurons labeled with IB4 in the spinal dorsal
horn were higher in number in Y1472F-KI mice than in
wild-type mice (Figure 6). (2) It has been reported that
the NGF level in the DRG increases in other neuropathic
pain model animals [33,34] and that NGF/TrkA signals
contribute to the development and maintenance of
neuropathic pain [35,36]. Although the NGF level was
previously reported to increase in the injured skin[12,37], it had returned to the basal level on day 50 after
the HSV-1 injection (Figure 4). Therefore it is unlikely
that NGF directly activated and/or sensitized the noci-
ceptors on free nerve endings at the postherpetic pain
phase. (3) The neurite outgrowth from adult DRGs pre-
pared from Y1472F-KI mice was similarly facilitated by
NGF, but the responsiveness of these mice to GDNF was
reduced as compared with that of wild-type mice to it
(Figure 8A). On the other hand, LDH release, indicative
of cell damage, was observed in wild-type DRG neurons
treated with glutamate at 0.5 mM, whereas no release
was observed in the case of the Y1472F-KI DRG
(Figure 8B). Taken together, these results demonstrate
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ered the incidence of postherpetic neuralgia. This notion
is consistent with earlier findings that the inhibition of
acute herpetic allodynia results in a decreased incidence
of delayed postherpetic allodynia [38].Conclusions
The application of the postherpetic pain model by HSV-
1 inoculation into Y1472F-KI mice is useful for examin-
ing the factors contributing to the transition from acute
herpetic pain to delayed postherpetic pain. Phosphoryl-
ation of the NR2B subunit was involved in the pathogen-
esis of neuropathic pain not only in the spinal cord but
also in that of postherpetic pain in the periphery.Methods
Animals
Animal experiments were approved by the Animal
Experimentation Committee of Kansai Medical Univer-
sity and the Animal Care Committee at University of
Toyama, and were carried out in accordance with the
National Institutes of Health Guide for the Care and Use
of Laboratory Animals. C57BL/6 mice were obtained
from Japan SLC (Shizuoka, Japan). Y1472F-KI mice were
generated by a knock-in technique, substituting Tyr1472
(Y) of NR2B subunit with Phe (F). The absence of
Tyr1472 phosphorylation was confirmed, and the mice
were backcrossed to the C57BL/6 J background as
described previously [9]. Eight- to 10-week old mice
were used for HSV-1 inoculation.HSV-1 inoculation
Mice were inoculated with HSV-1 as described previ-
ously [2]. Briefly, HSV-1 (7401 H strain; 1 × 106 plaque-
forming units in 10 μl) was inoculated onto the shin skin
on the lumbar dermatome of the right hind paw after
scarification with 27-gauge needles. The contralateral
hind paw was not inoculated.Assessment of allodynia
Punctate allodynia of the hind paw was assessed as
described previously [4]. Briefly, mice were acclimated to
the instrument, and then their plantar skin was pressed
by a von Frey filament having a bending force of 1.6 mN
(ca. 0.16 g). The responses to the stimulus were ranked
as follows: 0, no response; 1, lifting the hind paw; 2,
flinching or licking the hind paw. The stimulation was
applied 6 times, and the average served as the pain-
related score. Mice that showed 0.5 or higher as their
pain-related score were considered to have allodynia;
and those with ≥ 1.0, to have strong allodynia.Histology
On day 7 or 50 after the inoculation, the mice were
anesthetized with 50 mg/kg of pentobarbital and per-
fused transcardially with a fixative solution (4% parafor-
maldehyde in 0.1 M phosphate buffer, pH 7.4). The
hindlimb skin on the lumbar dermatome was harvested
from both inoculated and contralateral sides. The lum-
bar spinal cord was also harvested from the mice on
day 50 post-inoculation. Tissues were post-fixed by
immersion in the above-mentioned fixative solution at 4°C
overnight, and then incubated in 30% sucrose in
phosphate-buffered saline (PBS) overnight. Tissues were
frozen in Tissue MountW (Chiba Medical, Saitama, Japan)
or O.C.T. compound (Sakura Finetek, Tokyo, Japan) and
cut transversely into 10- or 20-μm sections on a cryostat.
The skin sections were stained with hematoxylin and eosin,
and images were captured with a color cooled charge-
coupled device camera mounted on a microscope (E1000;
Nikon, Tokyo, Japan).
Immunohistochemistry
Tissue sections were first incubated for 30 min in a
blocking solution (5% normal goat serum and 0.25%
Triton-X 100 in PBS) and then incubated with rat
monoclonal anti-SP antibody (1:100; AbD Serotec,
Oxford, UK) or rabbit polyclonal antibodies against
PGP9.5 (1:500; Abcam, Cambridge, UK) or CGRP
(1:4000, Sigma, St. Louis, MO), overnight at 4°C. After
having been washed with PBS, the sections were incu-
bated with Alexa 488-conjugated goat anti-rat or Alexa
546-conjugated goat anti-rabbit IgG antibody (1:500;
Invitrogen, Carlsbad, CA) for 1 h, and washed. The
sections were then counterstained and mounted with
coverslips by using Vectashield mounting medium con-
taining 4',6-diamidino-2-phenylindole (DAPI; Vector La-
boratories, Burlingame, CA). The fluorescent images
were obtained with a Zeiss laser scanning confocal
microscope (LSM 510 META; Carl Zeiss, Jena, Ger-
many). A stack of images of tissue sections was created
from a series of 34–48 consecutive images taken along
the z-axis, each having a 0.38-μm thickness, with Zeiss
C-Apochromat 40 x/1.2 W.
IB4 labeling
Sections of spinal cords were preincubated for 20 min at
room temperature with 0.1% Triton-X 100 in PBS sup-
plemented with 0.1 mM CaCl2, MgCl2, and MnCl2 and
then incubated overnight at 4°C with 50 μg/ml of fluor-
escein isothiocyanate-conjugated Bandeiraea simplicifo-
lia isolectin B4 (IB4, Sigma) in the preincubation buffer.
Quantitative image analysis
All image analyses were conducted with ImageJ software
(http://rsbweb.nih.gov/ij/). Quantification of epidermal
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done by using skin sections on day 50 post-inoculation.
As for PGP9.5-positive epidermal nerve fibers, 8 to 10
photos of the affected skin and 5 or 6 photos of the
contralateral skin were taken at regular intervals per sec-
tion per mouse.
The lengths of PGP9.5-positive intraepidermal nerve
fibers were measured with ImageJ software, and the total
length (per mm of epidermis) of all nerve fibers in each
image was calculated. The number of CGRP-positive
nerve fibers in the epidermis was counted in 3 sections
per mouse at a magnification of 630. The mean numbers
of nerve fibers per mm epidermis were calculated. For
measurement of CGRP-, SP-, and IB4-fluorescence in-
tensity in the spinal cord, every 6 sections of the dorsal
horn were analyzed per mouse. The fluorescent images
were converted to binary images, and the area of labeled
neurons was measured.
Enzyme-linked immunosorbent assay (ELISA)
On day 50 post-inoculation, the hair of mice was
clipped; and the hindlimb skin of both inoculated and
contralateral sides was harvested. A skin-wound model
was made as previously described [37]. Briefly, adult
C57BL/6 and Y1472F-KI mice were anesthetized by
pentobarbital, after which the hair on their back was
clipped and full-thickness skin wounds 5 mm in diam-
eter were prepared by cutting out the skin. After 24 h,
the skin approx. 2–3 mm around the wound was
obtained and stored at −80°C. The frozen skin was
ground into a powder in a mortar chilled by liquid nitro-
gen, and the skin powder was weighed. The powder was
then suspended in lysis buffer (20 mM Tris, 137 mM
NaCl, 1% NP40, 10% glycerol, 1 mM phenylmethylsulfo-
nyl fluoride, 10 μg/ml trasirol; pH 8), and the mixture
was subsequently stirred for 30 min on ice to extract
NGF. After centrifugation at 15,000 rpm for 20 min, the
supernatant was recovered; and the NGF content was
then measured by use of an ELISA kit (Promega,
Madison, WI) according to the manufacturer’s protocol.
PCR analysis
Total RNAs were extracted from L4 and L5 DRGs of
wild-type and Y1472F-KI mice on days 7 and 50 post-
inoculation by using Trizol reagent as recommended
by the manufacturer (Invitrogen). cDNAs were synthe-
sized from the RNA by use of reverse transcriptase
with p(dN)6 random primer. Real-time PCR was car-
ried out by using an MJ Research Opticon 2 system
(BioRad, Hercules, CA) with SYBR green and the follow-
ing primers (5'-to-3' direction): aagactggagcaaaatgatg and
gacttggtgactgacatctc for ATF3, cagacactctggatctagac
and gattggaggctcggcacttg for NGF, cgttgagaaagctgcttcag and
tcggctttgctcagtggatc for BDNF, ctgtctgcctggtgttgct andcgtcatcaaactggtcagga for GDNF, gagactgaatgaccgaactc
and tatccgcctggatcagcttg for NT3, and ttgggcgcctggtcac
cagggctgc and atttgccgtgagtggagtcatac for GAPDH. Each
sample was analyzed in triplicate, and the data were nor-
malized to GAPDH by using the comparative Ct method.
Electrophysiology
The methods used for obtaining spinal cord slice pre-
parations were described previously [39]. In brief, adult
wild-type and Y1472F-KI mice (8–10 weeks of age) were
deeply anesthetized by an intraperitoneal injection of
urethane (1.2 g/kg), and then lumbosacral laminectomy
was performed. The lumbosacral spinal cord (L1–S3)
was removed and placed in preoxygenated Krebs’ solu-
tion at 1–3°C. Immediately after the removal of the
spinal cord, the mice were given an overdose of urethane
and then killed by exsanguination. The pia-arachnoid
membranes were removed after cutting all the ventral
and dorsal roots near the root entry zone. The spinal
cord was mounted on a microslicer, and then a 650-
mm-thick transverse slice was cut. The slice was placed
on a nylon mesh in the recording chamber, which had
a volume of 0.5 ml, and was then perfused at a rate of
10–15 ml/min with Krebs’ solution saturated with 95%
O2 and 5% CO2 and maintained at 36 ± 1°C. The Krebs’
solution contained 117 mM NaCl, 3.6 mM KCl, 2.5 mM
CaCl2, 1.2 mM MgCl2, 1.2 mM NaH2PO4, 25 mM
NaHCO3, and 11 mM glucose (pH= 7.4).
Blind whole-cell patch-clamp recordings were made
from substantia gelatinosa (SG) neurons with patch-
pipette electrodes having a resistance of 5–10 MΩ [39].
The patch-pipette solution was composed of 135 mM
potassium gluconate, 5 mM KCl, 0.5 mM CaCl2, 2 mM
MgCl2, 5 mM EGTA, 5 mM HEPES, and 5 mM ATP-
Mg (pH= 7.2). Signals were acquired with a patch-clamp
amplifier (Axopatch 200B; Molecular Devices, Sunny-
vale, CA). Data were digitized with an A/D converter
(Digidata 1440A, Molecular Devices), stored, and ana-
lyzed with a personal computer using the pCLAMP data
acquisition program (Version 10.2, Molecular Devices).
SG neurons were viable for up to 24 h in slices perfused
with preoxygenated Krebs’ solution. However, all the
recordings described here were obtained within 12 h.
Whole-cell patch-clamp recordings were stable for up to
4 h. Drugs were dissolved in Krebs’ solution and applied
by perfusion via a 3-way stopcock without any change in
the perfusion rate or the temperature. The time neces-
sary for the solution to flow from the stopcock to the
surface of the spinal cord slice was approximately 10 sec.
DRG culture
L4, L5, and L6 DRGs were dissected from C57BL/6 and
Y1472F-KI mice at 4 to 5 weeks of age. Some mice were
subjected to a unilateral axotomy. The left sciatic nerve
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bital anesthesia. Seven days later, the animals were killed;
and their ganglia were then collected. The ganglia were
digested with 0.7 mg/ml collagenase type II (Sigma) in
Dulbecco's modified Eagle medium (DMEM) for 50 min
at 37°C followed by 0.05% trypsin-EDTA for 5 min at
37°C, and then the digestion was stopped by the addition
of 0.2 mg/ml of trypsin inhibitor (Sigma). The cells were
dispersed by pipetting and then filtered through a 70-μm
cell strainer (BD). The cell number was counted, and the
cells were plated onto poly-D-lysine and laminin-coated
glass cover slips (in 24-well plates) at a density of
2.5 × 103 cells/ml and cultured in Neurobasal medium
with 2% B27 supplement. To some wells 10–100 ng/ml
of NGF or GDNF (PeproTech, Rocky Hill, NJ) was
added, and the cells were then cultured at 37°C in a hu-
midified atmosphere containing 5% CO2. After 22–26 h
of culture, the neurons were fixed in 4% paraformaldehyde
for 15 min on ice and washed with PBS. Non-
specific binding sites were blocked with blocking solution
(2% bovine serum albumin, 0.25% Triton X-100 in PBS) for
30 min at room temperature, and then the fixed cells were
incubated overnight at 4°C with anti-PGP9.5 antibody
(Ultraclone) diluted 1:1000 in blocking solution. After
having been washed with PBS, the neurons were incubated
with a 1:500 dilution of Alexa 546-conjugated goat anti-
rabbit IgG (Invitrogen) for 1 h at room temperature and
washed in PBS. After the coverslips had been mounted to
glass slides with Vectashield (Vector Laboratories), the
immunostained neurons were observed with a Zeiss laser
scanning confocal microscope (LSM 510 META, Carl
Zeiss); and 200–400 cells per sample were counted to
measure the percentage of cells with neurite outgrowth.
The cells that extended neurites to a length greater than 2
cell-body diameters were classified as process-bearing
neurons.
Release of lactate dehydrogenase (LDH)
LDH release was measured with an LDH-Cytotoxic Test
kit (Wako Pure Chemicals, Osaka, Japan) according to
manufacturer's instructions. Briefly, after DRG neurons
(3,000/well) had been incubated without or with 0.1–1 mM
glutamate in a 96-well plate for 24 h, 50 μl of culture
medium was transferred from each well to a well
of another 96-well plate; and 50 μl of freshly prepared col-
oring solution was added to it. LDH activity was colorime-
trically measured at 560 nm by use of a plate reader
(Enspire 2300 Multilabel Reader, PerkinElmer, Waltham,
MA).
Statistics
Data were presented as mean ± standard deviation (SD).
The Mann–Whitney U-test was used for the statistical
analysis of allodynia data, and Bonferroni t-test or Student'st-test (two-tailed) was used for other analyses, by using
SigmaPlot ver. 12 (Systat Software, Inc., San Jose, CA).
P values of less than 0.05 were considered significant.
Additional file
Additional file 1: Figure S1. Cutaneous innervation in Thy1-YFP mice
on day 7 after inoculation. Thy1-YFP transgenic mice were obtained from
Jackson Laboratory (strain B6.Cg-Tg (thy1 YFP) 16Jrs/J). Ten-week-old
mice, weighing 20 ± 2 g, were inoculated with HSV-1 and the hindlimb
skin in the lumbar dermatome was harvested from the mice on day 7
after the inoculation. The fluorescent images were obtained with a Zeiss
laser scanning confocal microscope (LSM 510 META; Carl Zeiss, Jena,
Germany). Scale bar = 50 μm.
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